Taken together, these results indicated that PRR decoy inhibitor PRO20 (250 μg/kg/d or 500 μg/kg/d) retarded the TAC-induced cardiac hypertrophy and fibrosis. This evidence concerns the gene ATP6AP2 and persistent truncus arteriosus.